Skip to main content
U.S. flag

An official website of the United States government

Medical and Pharmaceutical

Federal Announcements

NSF Names Two New Innovation Engines in North Carolina, Announces $30 Million in New Investments to Region

| National Science Foundation (NSF) | Medical and Pharmaceutical, Textiles

The U.S. National Science Foundation announced two of the first-ever NSF Regional Innovation Engines as a part of President Biden’s Investing in America agenda. The two awardees are focused on regenerative medicine and driving innovation in textile manufacturing in regions anchored in North Carolina.

Read more

NIST Awards Nearly $3 Million to Small Businesses to Advance Semiconductor Manufacturing, Drug Development and More

| Department of Commerce (DOC), National Institute of Standards and Technology (NIST) | Medical and Pharmaceutical, Research and Development (R&D), Semiconductors, Small and Medium-sized Manufacturers, Small Business Innovation Research (SBIR)

The U.S. Department of Commerce’s National Institute of Standards and Technology has awarded nearly $3 million to 15 small businesses in nine states under the Small Business Innovation Research Program. The funding will go to research and development and commercialization projects to support a variety of technology-based programs such as advances in semiconductors, drug development and flexible electronics manufacturing.

Read more

NIST Awards $1,000,000 to the MEP Center in Virginia

| Department of Commerce (DOC), National Institute of Standards and Technology (NIST) | Medical and Pharmaceutical, Small and Medium-sized Manufacturers

The U.S. Commerce Department’s National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership (MEP) has made one cooperative agreement award totaling $1,000,000 as part of its 2021-NIST-MEP-CAP-01 Notice of Funding Opportunities (NOFOs). GENEDGE Alliance (GENEDGE), the MEP Center in Virginia, will lead a project, the Medical Manufacturer MedAccred Accreditation Pathway (MedMMAP Phase III).

Read more

Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics

| Department of Health and Human Services (DHHS) | COVID-19, Medical and Pharmaceutical

The U.S. Department of Health and Human Services awarded more than $1.4 billion for Project NextGen to support the development of a new generation of tools and technologies to protect against COVID-19. The awards follow extensive coordination with industry partners and include support for clinical trials that will enable the rapid development of more effective and longer-lasting coronavirus vaccines, a new monoclonal antibody and transformative technologies to streamline manufacturing processes.

Read more

Fact Sheet: HHS Announces ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured

| Department of Health and Human Services (DHHS) | COVID-19, Medical and Pharmaceutical

HHS is announcing the “HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program’ to maintain broad access to COVID-19 vaccines for millions of uninsured Americans. The program will create a unique $1.1 billion public-private partnership to help maintain uninsured individuals’ access to COVID-19 care at their local pharmacies, through existing public health infrastructure, and at their local health centers.

Read more

Related Reports

  • First Annual Report on Progress Towards Implementation of the American Pandemic Preparedness Plan

    | COVID-19, Healthcare, Medical and Pharmaceutical

    This document, released on the one-year anniversary of the public release of American Pandemic Preparedness: Transforming our Capabilities, provides the first annual report outlining progress towards implementation of relevant capabilities, highlights priority actions that are ongoing and needed across departments and agencies in the U.S. Government and the private sector, and identifies S&T opportunities to fill gaps and ensure that the Nation is properly prepared for emerging pandemic threats

    Read report

  • Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-Based Growth

    | Medical and Pharmaceutical, Semiconductors, Supply Chain

    The COVID-19 pandemic and resulting economic dislocation revealed long-standing vulnerabilities in our supply chains. The pandemic’s drastic impacts on demand patterns for a range of medical products including essential medicines wreaked havoc on the U.S. healthcare system. As the world shifted to work and learn from home, it created a global semiconductor chip shortage impacting automotive, industrial, and communications products, among others.

    Read report